{"wiki_id": "http://www.wikidata.org/entity/Q901998", "itemLabel": "Salvador Moncada", "itemDescription": "British pharmacologist", "wikipedia_url": "https://en.wikipedia.org/wiki/Salvador_Moncada", "wikipedia_page": {"main": "Sir Salvador Moncada, FRS, FRCP, FMedSci (born 3 December 1944) is a Honduran-British pharmacologist and professor. He is currently Research Domain Director for Cancer at the University of Manchester.In the past, he was the Research Director of the Wellcome Research Laboratories from 1986 to 1995 and, until recently, the Director of the UCL Wolfson Institute, which he established at University College London in 1996. His research interests include inflammation and vascular biology and he is currently working on the regulation of cell proliferation. He gained fame for his discoveries related to nitric oxide function and metabolism, and his exclusion from the 1996 Lasker Award and the 1998 Nobel Prize in medicine.", "link_mentions": [{"page": "Demographics of Honduras", "response": ["Examples of white Hondurans are ex president Simon Azcona del Hoyo, biomedic Salvador Moncada, film director Juan Carlos Fanconi, politician Roberto Micheletti, General Florencio Xatruch and former president of the Central American federation Don Francisco Moraz\u00e1n Quezada.", "File:EWS23.20.jpg|Sir. Salvador Moncada, Honduran biomedic"]}, {"page": "Leopold III of Belgium", "response": ["* Princess Marie-Esm\u00e9ralda of Belgium, later Lady Moncada, born in Brussels on 30 September 1956, a journalist, her professional name is Esmeralda de R\u00e9thy. She married pharmacologist Salvador Moncada in 1998. They have a son and a daughter."]}, {"page": "Monarchy of Belgium", "response": ["*Princess Marie-Esm\u00e9ralda, Lady Moncada (born 30 September 1956). She is the youngest daughter of Leopold III and Lilian, Princess of R\u00e9thy, half-sister of both Kings Baudouin and Albert II and half-aunt of King Philippe. Princess Marie-Esm\u00e9ralda is a journalist, writing under the name Esm\u00e9ralda de R\u00e9thy. She married Sir Salvador Moncada, a Honduran-British pharmacologist, in London on 4 April 1998. They have a daughter, Alexandra Leopoldine (born in London on 4 August 1998), and a son, Leopoldo Daniel (born in London on 21 May 2001)."]}, {"page": "Culture of Honduras", "response": ["Salvador Moncada is a scientist of Honduran origin. He is married to Princess Marie-Esm\u00e9ralda of Belgium. His principal area of study is pharmacology, especially with respect to the effects of products of the metabolism of diverse acids, as well as the synthesis, action, and degradation of the biological mediator nitric oxide."]}, {"page": "Moncada", "response": ["* Salvador Moncada (born 1944), Honduran scientist"]}, {"page": "John Vane", "response": ["In 1973, Vane left his academic post at the Royal College of Surgeons and took up the position as Director of Research at the Wellcome Foundation, taking a number of his colleagues with him who went on to form the Prostaglandin Research department.  Under the leadership of Salvador Moncada, this group continued important research that eventually led to the discovery of prostacyclin.\"Sir John R. Vane FRS, Nobel Laureate (1927\u20132004)\". William Harvey Research Foundation."]}, {"page": "List of Latin American Jews", "response": ["* Salvador Moncada, pharmacologist (Jewish mother)"]}, {"page": "Prostacyclin", "response": ["A team at The Wellcome Foundation led by Salvador Moncada had identified a lipid mediator they called \"PG-X,\" which inhibits platelet aggregation. PG-X, later known as prostacyclin, is 30 times more potent than any other then-known anti-aggregatory agent. They did this while searching for an enzyme that generates a fellow unstable prostanoid, Thromboxane A2", "In 1976, Vane and fellow researchers Salvador Moncada, Ryszard Gryglewski, and Stuart Bunting published the first paper on prostacyclin in  Nature.  The collaboration produced a synthesized molecule, which was named epoprostenol. But, as with native prostacyclin, the epoprostenol molecule is unstable in solution and prone to rapid degradation.  This presented a challenge for both in vitro experiments and clinical applications."]}, {"page": "List of Honduras-related topics", "response": ["*Sir Salvador Moncada"]}]}}